Literature DB >> 24996886

Drug treatments in people with intellectual disability and challenging behaviour.

Peter Tyrer1, Sally-Ann Cooper2, Angela Hassiotis3.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2014        PMID： 24996886     DOI： 10.1136/bmj.g4323

Source DB:  PubMed          Journal:  BMJ        ISSN： 0959-8138


× No keyword cloud information.
  7 in total

Review 1.  Prescribing psychotropic drugs to adults with an intellectual disability.

Authors:  Julian N Trollor; Carmela Salomon; Catherine Franklin
Journal:  Aust Prescr       Date:  2016-08-01

2.  Effects of clonidine on progressive ratio schedule performance in Fmr1 knockout mice.

Authors:  Craige C Wrenn; Eric French; Dustin Baker; Randall McCallian; Ryan Kirk; Mark P Reilly; Maria G Valdovinos
Journal:  Psychopharmacology (Berl)       Date:  2021-01-15       Impact factor: 4.530

3.  Towards onset prevention of cognition decline in adults with Down syndrome (The TOP-COG study): A pilot randomised controlled trial.

Authors:  Sally-Ann Cooper; Temitope Ademola; Muriel Caslake; Elizabeth Douglas; Jonathan Evans; Nicola Greenlaw; Caroline Haig; Angela Hassiotis; Andrew Jahoda; Alex McConnachie; Jill Morrison; Howard Ring; John Starr; Ciara Stiles; Chammy Sirisena; Frank Sullivan
Journal:  Trials       Date:  2016-07-29       Impact factor: 2.279

4.  Morbidity and mortality of women and men with intellectual and developmental disabilities newly initiating antipsychotic drugs.

Authors:  Simone N Vigod; Yona Lunsky; Virginie Cobigo; Andrew S Wilton; Sarah Somerton; Dallas P Seitz
Journal:  BJPsych Open       Date:  2016-04-20

5.  Mental illness, challenging behaviour, and psychotropic drug prescribing in people with intellectual disability: UK population based cohort study.

Authors:  Rory Sheehan; Angela Hassiotis; Kate Walters; David Osborn; André Strydom; Laura Horsfall
Journal:  BMJ       Date:  2015-09-01

6.  Anticholinergic burden in adult and elderly people with intellectual disabilities: Results from an Italian multicenter cross-sectional study.

Authors:  Luc Pieter De Vreese; Ulrico Mantesso; Elisa De Bastiani; Annachiara Marangoni; Elisabeth Weger; Tiziano Gomiero
Journal:  PLoS One       Date:  2018-10-31       Impact factor: 3.240

7.  Changes over a decade in psychotropic prescribing for people with intellectual disabilities: prospective cohort study.

Authors:  Angela Henderson; Paula Mcskimming; Deborah Kinnear; Colin McCowan; Alasdair McIntosh; Linda Allan; Sally-Ann Cooper
Journal:  BMJ Open       Date:  2020-09-10       Impact factor: 2.692
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.